English
French
German
Italian
Portuguese
SpanishLatest News from EU-PFF
Next webinar on Sep 25th at 6:45 pm CET: “Key developments in pulmonary fibrosis research – highlights from the 2023 ERS Congress”
The third session of a new series of monthly and free webinars for the pulmonary fibrosis...
POSTPF Study – the Imperial College London is looking for participants!
The Imperial College London is running a qualitative research project (meaning there are no...
Survey on treatment adherence in patients with PF – we need your help!
In the past few months, the Federation has been working on a survey to assess the extent to which pulmonary fibrosis patients adhere to their medications. In order for this survey to yield meaningful results and contribute to better health care for PF patients, we would like to ask you for your help and 20 minutes of your time.
Today is the first day of Pulmonary Fibrosis Awareness Month!
Today kicks off Pulmonary Fibrosis Awareness Month! It takes place every September and aims to raise awareness about Pulmonary Fibrosis, its challenges and the changes it brings to daily life, as well as the burden it places on patients and their loved ones
News from EU-PFF – Newsletter #1 2023
A lot has happened in the field of Pulmonary Fibrosis in the time since our last newsletter in...
Summary of “Key issues in management of ILD in patients with RA, SSc & other connective tissue diseases” available
The summary of the 2nd webinar in 2023 on “Key issues in management of ILD in patients with RA,...
Pulmonary Fibrosis CAB – Report on first meeting available
EU-PFF has set up a Pulmonary Fibrosis Community Advisory Board (PF-CAB) as a working group of the...
Second webinar on “Key issues in management of ILD in patients with RA, SSc & other connective tissue diseases” now available as a recording
The second webinar of a new series of monthly and free webinars for the Pulmonary Fibrosis...
EU-PFF Webinar “Key issues in management of ILD in patients with rheumatoid arthritis, systemic sclerosis and other connective tissue diseases” on June 28th
On April 23th the European Pulmonary Fibrosis Federation will launch a series of monthly and free...
Summary of “New treatments for PF” available
The summary of the first webinar in 2023 on “New treatments for PF” including subtitles in...
EU-PFF welcomes two new members from Hungary and Turkey
EU-PFF welcomes two new members which have been accepted as full members at the Annual General...
First webinar of 2023 on “New treatments for PF – What’s in the pipeline?” now available as a recording
The first webinar of a new series of monthly and free webinars for the Pulmonary Fibrosis...
EU-PFF Webinar “New treatments for Pulmonary Fibrosis – What’s in the pipeline?” on April 24th
On April 24th the European Pulmonary Fibrosis Federation will launch a series of monthly and free...
The EU-PFF Annual Report 2022 has been published
The EU-PFF Annual Report 2022 has been published. It contains news, information and updates about...
ELHG launches policy brief on improving lung health in the EU with renewed Air Quality Directives
More than 300,000 deaths per year due to air pollution are unacceptable, says the the European...
Clean Air in Europe for All opens its gates on May 24th
On May 24th, the European Respiratory Society (ERS), the International Society for Environmental...
Survey on the use of AI in healthcare
The European Respiratory Society is currently conducting a short survey to find out what patients,...
EU-PFF congratulates Jean-Michel Fourrier, Elina Vogiatzaki & Liam Galvin!
EU-PFF congratulates EU-PFF board member and AFPF President Jean-Michel Fourrier on being elected...
ERS International Congress 2023
The ERS (European Respiratory Society) International Congress 2023 will take place at MiCo in...
The WASOG Conference 2023 will take place from June 19-21 in Stockholm
The WASOG 2023 conference will take place from June 19–21 2023, at Aula Medica, Karolinska...